Tag Archives: clinical research

CLEAR Study Update: A look inside the collaboration between ERT and UCLA

Posted on October 1, 2012 by ertglobal

Written by: Michael Taylor – Senior Director, Healthcare Solutions As some of you may remember, back in February 2012, ERT collaborated with the University of California, Los Angeles (UCLA) to launch the CLEAR study, an innovative research study aimed at … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

2011 DIA Annual Meeting Recap

Posted on July 1, 2011 by ertglobal

Chicago, Illinois is home to the Willis (Sears) Tower, Blues Brothers, hot dogs, and deep dish pizza, but most importantly this year’s 47th DIA Annual Meeting.  The Annual Meeting has always been and will continue to be an important conference for … Continue reading →

Posted in Clinical Research, Clinical Trials, DIA, DIA Annual Meeting, Drug Information Association, Pharmaceutical | Tagged , , , , , | Leave a comment

ePRO Webinar Series – Prospectively Monitoring for Suicidality + Bonus Q&A Session

Posted on May 26, 2011 by ertglobal

On April 6, 2011, ERT held a webinar on prospectively monitoring for suicidality in non-mental health indications that included guest speakers: Kelly Posner, Ph.D, Columbia University, John Greist, M.D., HTS, and Michael Federico, VP ePRO Solutions, ERT.  Such an important issue drew in … Continue reading →

Posted in Clinical Trials, eC-SSRS, ePRO, Patient Reported Outcomes, Pharmaceutical, Suicidality Monitoring | Tagged , , , , , , , , | Leave a comment

ERT at DIA 2011 47th Annual Meeting

Posted on May 23, 2011 by ertglobal

The largest and most respected event for the biopharmaceutical, medical device, and related health care industries, is quickly approaching.  On June 19-23, ERT, as well as approximately 550 other companies will be exhibiting at the highly regarded and valuable 47th … Continue reading →

Posted in Clinical Research, Clinical Trials, DIA, DIA Annual Meeting, Drug Information Association, Pharmaceutical, Uncategorized | Tagged , , , | Leave a comment

Spirometry Basics and Centralization

Posted on April 29, 2011 by ertglobal

Approximately 15% of the world‘s population suffer from Respiratory diseases such as Asthma, COPD or others.  Most Respiratory Diseases are classified as either obstructive, which are an inflammatory condition of the airway, or restrictive, which are characterized by reduced total lung … Continue reading →

Posted in Clinical Trials, FDA, Pharmaceutical, Respiratory, Spirometry | Tagged , , , , , , , | Leave a comment

Strategic Alliances & Partner Relationships

Posted on March 31, 2011 by ertglobal

Hello and welcome, we are bringing this to you live from Arizona!  We are here attending the Partnerships in Clinical Trials conference, and so far everything is going great! This post, will discuss the strategic alliances and partner relationships that have … Continue reading →

Posted in Clinical Research, Clinical Trials, Pharmaceutical | Tagged , , | Leave a comment

The Diabetes Pandemic: Responding to FDA Guidance on Cardiovascular Risk in Type 2 Diabetes Treatment with Cardiologist, Dr. Robert Kleiman.

Posted on February 22, 2011 by ertglobal

Welcome back!  This information has been provided by board-certified cardiologist, Dr. Robert Kleiman. Each of you reading today most likely knows someone who is personally affected by Diabetes, as Diabetes is increasing at a disturbing rate in the US, Europe and … Continue reading →

Posted in Cardiac Safety, Clinical Research, FDA, Pharmaceutical | Tagged , , , | Leave a comment